Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 3Phase 1/2 3Phase 1 3

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

NETWORK 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 1

Conditions

Colorectal Neoplasms 16Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasm Metastasis 3Gastrointestinal Stromal Tumors 2Carcinoma, Hepatocellular 2Carcinoma 2Adenocarcinoma 2Spinocerebellar Degenerations 1HER2-positive Colorectal Cancer 1HER2 IHC3+ Advanced Colorectal Cancer 1Colorectal Cancer Liver Metastases 1Colonic Neoplasms 1Advanced Colorectal Cancer 1

Interventions

Leucovorin 22Fluorouracil 22Gemcitabine 21Capecitabine 21Paclitaxel 20Docetaxel 20Irinotecan 15Carboplatin 15Radiosurgery 14Oxaliplatin 13Cisplatin 13Bevacizumab 13Zoledronic Acid 12pembrolizumab 11Radiotherapy 11Fulvestrant 11palbociclib 9Pemetrexed 9Drug Therapy 9130-nm albumin-bound paclitaxel 9Surgical Procedures, Operative 7Letrozole 7Ibandronic Acid 7abemaciclib 6Trastuzumab 6Prednisone 6Vinorelbine 5Folfox protocol 5Floxuridine 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Metastasis × regorafenib × Clear all
NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting
450 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT02773524 2022-01-13

INTEGRATEIIa

Australasian Gastro-Intestinal Trials Group

Phase 3 Unknown
250 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT01584830 2016-02-08

CONCUR

Bayer

Phase 3 Completed
204 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡